For decades, access to prescription drugs has been treated more like a luxury than a public good in the United States, even though taxpayers pay for much of the research that funds the development of these drugs. This legislation, which would start to rein in the drug corporations’ monopoly power, will have an outsized impact on the millions of Americans struggling to afford their medicines every year.
Big Pharma’s greed knows no limits. While people across the country lost their incomes and healthcare over the last year, the CEOs of these corporations amassed hundreds of millions of dollars on the backs of American families thanks to billions in taxpayers funds that they received for treatments and vaccines. The same corporations that are bragging about the vaccine that people are now getting for free are predictably already plotting about how they’ll make us pay to boost profits later, once the pandemic is over.
Secretary Becerra has the skills and experience to help America tackle some of the most pressing issues before us: a raging pandemic, inaccessible healthcare, and sky-high prescription drug prices. We’re glad the Senate has finally approved him so he can get to work for the American people.
In a new letter to Democratic leaders in Congress, Lower Drug Prices Now—a coalition of 60 social, racial, and economic justice organizations representing millions of Americans struggling with high prescription drug prices—urges House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer to pass a strong H.R. 3, the Lower Drug Costs Now Act in order to make prescription drugs more affordable and hold the pharmaceutical industry accountable for price gouging and pandemic profiteering.
This announcement from the Federal Trade Commission is big news, and an important step toward advancing a healthcare system that guarantees every American can afford the medicines they need.
The American Rescue Plan will expand access to Medicaid and make healthcare affordable for millions of people across the country, while simultaneously beginning to rein in Big Pharma’s price gouging. We will be watching to make sure that the Medicaid Rebate Cap provision will ultimately be implemented in 2024 rather than falling prey to Big Pharma lobbyists. Democrats have committed to put people before Big Pharma profits, and we’ll hold them to that.
We all share President Biden’s goal to ensure that every person has access to a COVID vaccine, no matter where they live, what they look like, or how much money they have. To truly accomplish this, when the President meets with executives from Johnson & Johnson and Merck at the White House, he must discuss the industry’s active role in controlling access to the prescription drug through exclusive patents that guarantee the corporations big profits on all kinds of medicines–including ones funded by taxpayer dollars like COVID vaccines.
